Shawn Olsson Biography and Net Worth

Insider of LENZ Therapeutics

Shawn Olsson has served as LENZ’s Chief Commercial Officer since April 2021. Previously, from March 2018 to April 2021, Mr. Olsson served as Vice President of North American Marketing and Global Portfolio and Vice President of North American Marketing at Xellia Pharmaceuticals, a pharmaceuticals and life sciences company. From September 2015 to March 2018, Mr. Olsson served as Director, Global Sterile Injectables on Market Strategy Lead and Commercial Lead, Opioids and Syringe Technology Portfolio at Pfizer (NYSE: PFE), a multinational pharmaceutical and biotechnology company.

What is Shawn Olsson's net worth?: The estimated net worth of Shawn Olsson is at least $45.93 thousand as of November 17th, 2025. Olsson owns 4,733 shares of LENZ Therapeutics stock worth more than $45,929 as of May 7th. This net worth estimate does not reflect any other investments that Olsson may own. Learn More about Shawn Olsson's net worth.
How do I contact Shawn Olsson?: The corporate mailing address for Olsson and other LENZ Therapeutics executives is 611 Gateway Blvd Suite 120, SOUTH SAN FRANCISCO CA, 94080. LENZ Therapeutics can also be reached via phone at 650-484-0886 and via email at [email protected]. Learn More on Shawn Olsson's contact information.
Has Shawn Olsson been buying or selling shares of LENZ Therapeutics?: Shawn Olsson has not been actively trading shares of LENZ Therapeutics during the past quarter. Most recently, Shawn Olsson sold 10,000 shares of the business's stock in a transaction on Monday, November 17th. The shares were sold at an average price of $26.10, for a transaction totalling $261,000.00. Following the completion of the sale, the insider now directly owns 4,733 shares of the company's stock, valued at $123,531.30. Learn More on Shawn Olsson's trading history.
Who are LENZ Therapeutics' active insiders?: LENZ Therapeutics' insider roster includes Daniel Chevallard (CFO), James McCollum (Director), and Shawn Olsson (Insider). Learn More on LENZ Therapeutics' active insiders.
Are insiders buying or selling shares of LENZ Therapeutics?: In the last twelve months, LENZ Therapeutics insiders bought shares 2 times. They purchased a total of 12,698 shares worth more than $289,321.48. In the last twelve months, insiders at the sold shares 1 times. They sold a total of 10,000 shares worth more than $261,000.00. The most recent insider tranaction occured on November, 17th when insider Shawn Olsson sold 10,000 shares worth more than $261,000.00. Insiders at LENZ Therapeutics own 6.9% of the company. Learn More about insider trades at LENZ Therapeutics.
Information on this page was last updated on 11/17/2025.

Shawn Olsson Insider Trading History at LENZ Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/17/2025	Sell	10,000	$26.10	$261,000.00	4,733

Shawn Olsson Buying and Selling Activity at LENZ Therapeutics

LENZ Therapeutics Company Overview

LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.

Today's Range

Now: $9.73

$9.36

$9.74

50 Day Range

MA: $10.55

$8.29

$13.68

2 Week Range

Now: $9.73

$8.25

$50.40

Volume

155,712 shs

Average Volume

988,183 shs

Market Capitalization

$305.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.62